Distinguishing caffeine expectancy from pharmacological effects: a comparative review of experimental designs with future directions
Résumé
Caffeine (CAF) is among the most widely consumed bioactive substances and is recognized for its ergogenic benefits. Yet, separating its expectancy-driven effects from pharmacological effects remains challenging. This review compares the randomized double-blind placebo-controlled crossover, deceptive placebo-balanced, and double-deceptive placebo-balanced crossover designs commonly used in CAF studies. While the double-blind crossover design effectively controls individual variability, it cannot directly measure expectancy. In contrast, placebo-balanced crossover designs incorporating deception provide the most comprehensive framework when the aim is to separate pharmacological and expectancy-related effects, allowing a more precise interpretation of caffeine's mechanisms. Differences in studies designs may partially explain inconsistencies in the literature, as expectancy-related components are not equally controlled across experimental approaches.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 01/10/2026. Le document reste hébergé par sa source.
Voir le document à la source →